These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 12190175

  • 1. Hepatorenal syndrome: diagnostic accuracy, clinical features, and outcome in a tertiary care center.
    Watt K, Uhanova J, Minuk GY.
    Am J Gastroenterol; 2002 Aug; 97(8):2046-50. PubMed ID: 12190175
    [Abstract] [Full Text] [Related]

  • 2. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.
    Hepatogastroenterology; 2003 Aug; 50(54):1753-5. PubMed ID: 14696397
    [Abstract] [Full Text] [Related]

  • 3. Review article: hepatorenal syndrome--definitions and diagnosis.
    Moreau R, Lebrec D.
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():24-8; discussion 29-30. PubMed ID: 15335396
    [Abstract] [Full Text] [Related]

  • 4. Precipitating Factors and Outcome of Hepatorenal Syndrome in Liver Cirrhosis.
    Chinnasamy V, Dhande SK, Kumar KM, M J.
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116041
    [Abstract] [Full Text] [Related]

  • 5. Outcomes for hepatorenal syndrome and acute kidney injury in patients undergoing liver transplantation: a single-center experience.
    Shusterman B, Mchedishvili G, Rosner MH.
    Transplant Proc; 2007 Jun; 39(5):1496-500. PubMed ID: 17580171
    [Abstract] [Full Text] [Related]

  • 6. Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT).
    Ruiz R, Barri YM, Jennings LW, Chinnakotla S, Goldstein RM, Levy MF, McKenna GJ, Randall HB, Sanchez EQ, Klintmalm GB.
    Liver Transpl; 2007 Jun; 13(6):838-43. PubMed ID: 17539003
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practice.
    Salerno F, Cazzaniga M, Merli M, Spinzi G, Saibeni S, Salmi A, Fagiuoli S, Spadaccini A, Trotta E, Laffi G, Koch M, Riggio O, Boccia S, Felder M, Balzani S, Bruno S, Angeli P, Italian Association of the Hospital Gastroenterologists (AIGO) investigators.
    J Hepatol; 2011 Dec; 55(6):1241-8. PubMed ID: 21703199
    [Abstract] [Full Text] [Related]

  • 8. [Hepatorenal syndrome].
    Mijac D, Kezić A, Stojimirović B.
    Srp Arh Celok Lek; 2007 Dec; 135(1-2):98-104. PubMed ID: 17503577
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome of patients treated with terlipressin for types 1 and 2 hepatorenal syndrome.
    Testro AG, Wongseelashote S, Angus PW, Gow PJ.
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1535-40. PubMed ID: 17784863
    [Abstract] [Full Text] [Related]

  • 10. Hepatorenal syndrome.
    Cárdenas A, Gines P.
    Clin Liver Dis; 2006 May; 10(2):371-85, ix-x. PubMed ID: 16971267
    [Abstract] [Full Text] [Related]

  • 11. Hepatorenal syndrome.
    Biswas KD, Jain AK.
    Trop Gastroenterol; 2002 May; 23(3):113-6. PubMed ID: 12693150
    [Abstract] [Full Text] [Related]

  • 12. [Cox regression analysis of predictive factors of hepatorenal syndrome].
    Zhang WJ, Yang DH, Shu JC.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):586-7. PubMed ID: 14572331
    [Abstract] [Full Text] [Related]

  • 13. The hepatorenal syndrome in liver transplant recipients.
    Seu P, Wilkinson AH, Shaked A, Busuttil RW.
    Am Surg; 1991 Dec; 57(12):806-9. PubMed ID: 1746799
    [Abstract] [Full Text] [Related]

  • 14. Hepatorenal syndrome in the intensive care unit.
    Wadei HM, Gonwa TA.
    J Intensive Care Med; 2013 Dec; 28(2):79-92. PubMed ID: 21859679
    [Abstract] [Full Text] [Related]

  • 15. [Hepatorenal syndrome].
    Pŭrvanov P.
    Khirurgiia (Sofiia); 2002 Dec; 58(2):34-9. PubMed ID: 12515019
    [Abstract] [Full Text] [Related]

  • 16. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
    Martín-Llahí M, Pépin MN, Guevara M, Díaz F, Torre A, Monescillo A, Soriano G, Terra C, Fábrega E, Arroyo V, Rodés J, Ginès P, TAHRS Investigators.
    Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
    [Abstract] [Full Text] [Related]

  • 17. Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furosemide infusion according to the central venous pressure: a prospective pilot study.
    Péron JM, Bureau C, Gonzalez L, Garcia-Ricard F, de Soyres O, Dupuis E, Alric L, Pourrat J, Vinel JP.
    Am J Gastroenterol; 2005 Dec; 100(12):2702-7. PubMed ID: 16393223
    [Abstract] [Full Text] [Related]

  • 18. Does hepatorenal syndrome affect the result of liver transplantation? Clinical observations.
    Park I, Moon E, Hwang JA, Yu S, Kim BW, Wang HJ, Shin GT, Kim H.
    Transplant Proc; 2010 Sep; 42(7):2563-6. PubMed ID: 20832544
    [Abstract] [Full Text] [Related]

  • 19. Pathophysiology, clinical features and management of hepatorenal syndrome.
    Garzia P, Ferri GM, Ilardi M, Messina FR, Amoroso A.
    Eur Rev Med Pharmacol Sci; 1998 Sep; 2(5-6):181-4. PubMed ID: 10710816
    [Abstract] [Full Text] [Related]

  • 20. Terlipressin therapy for renal failure in cirrhosis.
    Triantos CK, Samonakis D, Thalheimer U, Cholongitas E, Senzolo M, Marelli L, Leandro G, Patch D, Burroughs AK.
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):481-6. PubMed ID: 19952764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.